Deep Dive Into Immunocore Hldgs Stock: Analyst Perspectives (9 Ratings)
Deep Dive Into Immunocore Hldgs Stock: Analyst Perspectives (9 Ratings)
深入探讨Immunocore Hldgs股票：分析师观点（9个评级）
Ratings for Immunocore Hldgs (NASDAQ:IMCR) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中，9位分析师提供了Immunocore Hldgs（纳斯达克股票代码：IMCR）的评级，显示了看涨和看跌的观点。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的收视率，展示了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $86.44, a high estimate of $100.00, and a low estimate of $66.00. This current average represents a 0.77% decrease from the previous average price target of $87.11.
分析师通过对12个月目标股价的评估提供了更深入的见解，显示平均目标价为86.44美元，最高估计为100.00美元，低估值为66.00美元。目前的平均价格比之前的平均目标股价87.11美元下降了0.77％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级：全面细分
The analysis of recent analyst actions sheds...
对分析师最近行...
登录免费看全文
登录/注册